This effort aims to stimulate research in a major gap area in pediatric psychopharmacology for psychiatric and neurodevelopmental disorders, by encouraging the development of objective pediatric central nervous system (CNS) measures that can be incorporated into pharmacologic trials.

This is a re-issue of a long-standing R25 program announcement. The overarching goals of this initiative are to: (1) complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs; (2) help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral, and clinical […]

The purpose of the Conte Centers program is to support interdisciplinary teams of researchers engaged in novel, creative, and integrated experimental approaches to address high-risk, high-impact scientific questions in either basic neuroscience research or in translational research that will significantly advance the state of the science in brain and behavioral research and provide the foundation […]

This is a re-issue of a long-standing R25 program announcement that aims to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To address this goal, this concept would focus specifically on mentoring activities and in particular, mentoring networks.

This is a re-issue of a long-standing R25 program announcement that aims to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To address this goal, this concept would focus specifically on mentoring activities and in particular, mentoring networks.

This concept aims to support research to identify, optimize, and test solutions to enhance the effectiveness, quality, and availability of U.S. suicide prevention services.

The goal of this concept is to support research that addresses the optimization, effectiveness, implementation, coordination, and sustainability of empirically-supported therapeutic and services interventions within and across care settings to better meet the mental health needs of older adults with serious mental illness (SMI).

The goal of this concept is to encourage research that aims to better understand the mechanisms and potential therapeutic impact of fast-acting psychotomimetic agents.

The goal of this concept is to support the extension of the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Data Processing, Analysis and Coordination Center to complete final data processing and analysis required to complete the study.

The National Institutes of Health has funded six projects to develop, test, and validate outcome-focused quality measures for mental health, which are used to understand the impact of interventions when implemented in real-world health care systems and settings.